Litigation Details for Cytiva Sweden AB v. Bio-Rad Laboratories, Inc. (D. Del. 2018)

Cytiva Sweden AB v. Bio-Rad Laboratories, Inc. (D. Del. 2018)

Docket		Date Filed	2018-11-29
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	Plaintiff	Referred To	Sherry R. Fallon
Patents	7,022,014; 8,535,536; 8,663,194; 9,095,404
Link to Docket	External link to docket

Biologic Drugs cited in Cytiva Sweden AB v. Bio-Rad Laboratories, Inc.

Details for Cytiva Sweden AB v. Bio-Rad Laboratories, Inc. (D. Del. 2018)

Date Filed	Document No.	Description	Snippet	Link To Document
2020-09-23	148	Exhibit 1-9	:16 42:6, 42:14, 54:24 20:5, 21:7, 22:14, search [1] - 30:15 23:20, 30…9,709,589 (the “’589 Patent”), U.S. Patent No. 9,709,590 (the “’590 Patent”), U.S. Patent No. 9,709,591 (the …591 Patent”), and U.S. Patent No. 9,671,420 (the “’420 Patent”). 6. “Related Patents” shall… 5. “Patents-in-Suit” and “Asserted Patents” shall mean United States Patent No. 9,709,589 …shall mean all patents and patent applications claiming priority to Patent Application No. 0950431-7 filed	External link to document
2021-01-18	224	Exhibit A-S	Stephenson, Bruce K. Gale, and Cynthia Furse. 9. Patent No. 8,535,536 Cross-flow split-thin-flow cell, Bruce K… in the asserted patents and the representations the inventors made to the patent office to obtain …analysis of the patent, the statements the inventors made to obtain their patents, and the actual modules…591 Patent 1. The NGC System Does Not Infringe Claim 9 of the ’591 Patent at … claim 1 of the ’591 patent is nearly identical to claim 1 of the ’420 patent. Thus, I incorporate	External link to document